CMMI Issues Report on Status of Pending Drug Models | Manatt, Phelps & Phillips, LLP

The Center for Medicare and Medicaid Innovation (CMMI) has provided new updates on CMS’ planned initiatives to address prescription drug costs in a blog post from Director Liz Fowler....

Related Keywords

Xavier Becerra ,Joe Biden ,Liz Fowler ,Phelps Phillips ,Human Services ,Innovation Center ,Manatt On Health ,Drug Administration ,Department Of Health ,Approval Program ,Medicaid Innovation ,Director Liz ,Accelerating Clinical Evidence Model ,Executive Order ,President Joe Biden ,Secretary Xavier Becerra ,Accelerating Clinical Evidence ,Accelerated Approval Program ,Gene Therapy Access Model ,List Model ,Prescription Drug Plan ,Medicare Advantage ,Inflation Reduction Act ,